Article Details

Grifols' Anti-SARS-CoV-2 Hyperimmune Globulin Begins Clinical Trial In Patients With COVID-19

Retrieved on: 2021-01-22 14:36:47

Tags for this article:

Click the tags to see associated articles and topics

Grifols' Anti-SARS-CoV-2 Hyperimmune Globulin Begins Clinical Trial In Patients With COVID-19. View article details on hiswai:

Excerpt

For the trial Grifols has collected convalescent plasma from healthy recovered COVID-19 donors, in the U.S. using its plasma-center network and in ...

Article found on: thecorner.eu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up